USE OF THE I-RNA IN THE PHARMACEUTICALS FOR INCREASING OF THE AMOUNT OF PROTEIN ENCODED BY SAID RNA IN PATIENT CELLS

摘要

This invention is devoted to use of ribonucleic acids in medicinal substances including compositions, vaccines, transplants, intended for medical treatment, prophylactic treatment, cosmetic care; to injection of these substances into patient's organism. So it is possible to introduce ferments, hormones, antibiotics, proteins of cell receptors, structural proteins directly into cells of an organism. It is possible to reduce ribosomal and transport RNAs together with messenger RNA. When there is introduced RNA coding particular hormone or antibiotic, proteins of cell receptor or structural proteins, into recipient's organism, these substances will be synthesized directly in recipient's cells. Use of RNA instead of protein combinations gains an advantage over other analogues already by the fact that the RNA has no immunogenic properties and therefore causes no unwanted inflammatory reactions. RNA is used to supplement vaccine or another substance which is intended to activate patient's immunity against antigens existing in said substance, having removed from said substances or inactivated beforehand part or all the RNA taking part in synthesis of immunogenic substances against which it is wanted to activate patient's immunity.